Doctors at Sarasota Memorial Hospital say a new early detection program is helping catch more lung cancers before symptoms ...

Lung transplant recipients require intensive, ongoing monitoring after transplant to detect complications such as rejection ...

Screening guidelines often fail to pinpoint who’s at risk, and few people who are eligible for screening actually get checked ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...

Why should you know the number-one sign of lung cancer? While prostate cancer is more common in men and breast cancer is more common in women, more Americans die of lung cancer every year than of ...

PUEBLO, Colo. (KOAA) — UCHealth Parkview has announced that it's expanding access to advanced lung diagnostics in southern Colorado with the Ion robotic bronchoscopy system, a technology that allows ...

Barry Manilow is pulling the curtain back on his battle with lung cancer. Months after revealing a lung cancer diagnosis, the "Copacabana" singer is opening up about how the experience shaped his ...

He made it through the rain — now Barry Manilow is opening up about his “nightmare” lung cancer diagnosis and treatment. In December, the music icon, 82, revealed that he had been diagnosed with lung ...

Sponsored and provided by LifeBridge Health. Dr. Joseph Bennett is the System Chief of Surgery with LifeBridge Health. In this ASK A DOC, Dr. Bennett talks about the new Ion Robotic-Assisted ...

LMH Health, 325 Maine St., is pictured in May 2021. “The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects. Lung cancer is one of the ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung ...

bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...